Cargando…
Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy
Activation-induced cytidine deaminase (AID) is one kind of the mutant enzymes, which target regulating the immunoglobulin (Ig) gene in Burkitt’s lymphoma to initiate class switch recombination (CSR), resulting in c-Myc chromosomal translocation. However, it is not clear that whether AID induces c-My...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447639/ https://www.ncbi.nlm.nih.gov/pubmed/32843697 http://dx.doi.org/10.1038/s41598-020-71058-y |
_version_ | 1783574343323746304 |
---|---|
author | Zhang, Jingcheng Shi, Yifen Zhao, Mingzhe Hu, Huixian Huang, He |
author_facet | Zhang, Jingcheng Shi, Yifen Zhao, Mingzhe Hu, Huixian Huang, He |
author_sort | Zhang, Jingcheng |
collection | PubMed |
description | Activation-induced cytidine deaminase (AID) is one kind of the mutant enzymes, which target regulating the immunoglobulin (Ig) gene in Burkitt’s lymphoma to initiate class switch recombination (CSR), resulting in c-Myc chromosomal translocation. However, it is not clear that whether AID induces c-Myc/IgH translocation in double-hit lymphoma (DHL) with c-Myc gene translocation. In this study, the AID in DHL tissues and classical diffuse large b-cell lymphoma (DLBCL) tissues were compared. The results suggested that AID is of important value in predicting DHL, stronger CSR of AID was observed in DHL patients, which exhibited AID overexpression and c-Myc gene translocation of DHL after CSR induction. It is concluded that AID directly induces CSR in DHL and may result in c-Myc gene translocation. Targeting AID may be a good treatment regimen for DHL. |
format | Online Article Text |
id | pubmed-7447639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-74476392020-08-26 Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy Zhang, Jingcheng Shi, Yifen Zhao, Mingzhe Hu, Huixian Huang, He Sci Rep Article Activation-induced cytidine deaminase (AID) is one kind of the mutant enzymes, which target regulating the immunoglobulin (Ig) gene in Burkitt’s lymphoma to initiate class switch recombination (CSR), resulting in c-Myc chromosomal translocation. However, it is not clear that whether AID induces c-Myc/IgH translocation in double-hit lymphoma (DHL) with c-Myc gene translocation. In this study, the AID in DHL tissues and classical diffuse large b-cell lymphoma (DLBCL) tissues were compared. The results suggested that AID is of important value in predicting DHL, stronger CSR of AID was observed in DHL patients, which exhibited AID overexpression and c-Myc gene translocation of DHL after CSR induction. It is concluded that AID directly induces CSR in DHL and may result in c-Myc gene translocation. Targeting AID may be a good treatment regimen for DHL. Nature Publishing Group UK 2020-08-25 /pmc/articles/PMC7447639/ /pubmed/32843697 http://dx.doi.org/10.1038/s41598-020-71058-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Zhang, Jingcheng Shi, Yifen Zhao, Mingzhe Hu, Huixian Huang, He Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy |
title | Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy |
title_full | Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy |
title_fullStr | Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy |
title_full_unstemmed | Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy |
title_short | Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy |
title_sort | activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447639/ https://www.ncbi.nlm.nih.gov/pubmed/32843697 http://dx.doi.org/10.1038/s41598-020-71058-y |
work_keys_str_mv | AT zhangjingcheng activationinducedcytidinedeaminaseoverexpressionindoublehitlymphomapotentialtargetfornovelanticancertherapy AT shiyifen activationinducedcytidinedeaminaseoverexpressionindoublehitlymphomapotentialtargetfornovelanticancertherapy AT zhaomingzhe activationinducedcytidinedeaminaseoverexpressionindoublehitlymphomapotentialtargetfornovelanticancertherapy AT huhuixian activationinducedcytidinedeaminaseoverexpressionindoublehitlymphomapotentialtargetfornovelanticancertherapy AT huanghe activationinducedcytidinedeaminaseoverexpressionindoublehitlymphomapotentialtargetfornovelanticancertherapy |